Primary Care Physicians' Use of Stop-Smoking Plans to Help Patients Who Are Smokers

Official Title: “Using Electronic Medical Records to Measure and Improve Adherence to Tobacco Treatment Guidelines in Primary Care”

RATIONALE: Stop-smoking plans suggested by physicians may help patients quit smoking.

Studying how physicians give stop-smoking treatment as family doctors may increase the chance of smokers receiving such treatment.

PURPOSE: This randomized clinical trial is studying physicians' practice patterns to see if regular feedback to the physician increases the chance of adult smokers receiving stop-smoking treatment.

OBJECTIVES: - Develop an automated coding system using existing electronic medical records (EMRs) to assess adherence to national tobacco-cessation treatment guidelines by individual physicians in the primary care setting at 4 health maintenance organizations. - Compare the validity of the automated coding system with that of coding performed by medical record abstractors. - Determine the effect of performance feedback on tobacco treatment practice patterns over 2 years among primary care physicians. - Provide recommendations for recording tobacco-cessation treatment services in EMR systems and evaluating adherence to treatment guidelines. - Produce a set of computer programs that can be easily adopted in diverse health care settings for assessing adherence to the national tobacco-cessation treatment guidelines using data from EMRs.

OUTLINE: This is a randomized, controlled, multicenter study. Physicians from each participating center are sorted into pairs according to their rate of providing advice to quit smoking to identified adult smokers and the number of identified adult smokers seen in the 3-month baseline observation period. Each physician in the pair is then randomized to 1 of 2 arms. - Arm I (automated coding system feedback): Physicians receive reports from an automated coding system regarding their performance in administering tobacco-cessation services in each of the five A's (Ask, Advise, Assess, Assist, and Arrange) to identified smokers in comparison with their past performance and in comparison with their anonymous colleagues once every 3 months. One year after randomization, these physicians are further randomized, using the same paired-group approach, to either continue receiving automated coding system feedback for 1 additional year OR to stop receiving feedback.

Physicians receive a survey at the end of 2-year period regarding the usefulness of each aspect of the feedback reports and the feedback program in general. - Arm II (control): Physicians do not receive any information regarding their performance in administering tobacco-cessation services in each of the five A's to identified smokers.

A questionnaire about tobacco-cessation services in primary care is sent to patients of all physicians within two weeks of each patient's primary care visit and then at the end of the first year of providing feedback to physicians to compare patient report of tobacco-cessation services with what is documented in the electronic medical record for that primary care visit.

PROJECTED ACCRUAL: At least 40 primary care physicians per participating center and 1,000 patients (250 per participating center) will be accrued for this study.

Intervention(s) in this Clinical Trial

• Behavioral: smoking cessation intervention
• Other: counseling intervention

Primary Measures

• Change in tobacco cessation care delivery of the 5 A's (Ask, Advise, Assess, Assist, and Arrange) and in the percentage of smokers receiving assistance as measured by MediClass classification at 18 months
  • Safety Issue?: No

DISEASE CHARACTERISTICS:

• Primary care physician, meeting all of the following criteria:
• Practicing medicine in a family practice or internal medicine clinic
• Scheduled to see adult primary care patients for ≥ 2½ days (or 5 half days or equivalent combination of full and half days) per week
• Planning to continue full-time practice in their participating organization for at least the next 2 years
• At least 1 year of experience working with the local electronic medical record system
• Patient
• Adult smoker who visited a study physician within the past month

PATIENT CHARACTERISTICS:

• Age
• Adult
• Performance status
• Not specified
• Life expectancy
• Not specified
• Hematopoietic
• Not specified
• Hepatic
• Not specified
• Renal
• Not specified

PRIOR CONCURRENT THERAPY:

• Biologic therapy
• Not specified
• Chemotherapy
• Not specified
• Endocrine therapy
• Not specified
• Radiotherapy
• Not specified
• Surgery
• Not specified

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Lead Investigator: Kaiser Permanente Other

Overall Clinical Trial Officials and Contacts

Victor J. Stevens, PhD Study Chair Kaiser Permanente  

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00227786

Study ID Number: CDR0000448865

ClinicalTrials.gov Identifier: NCT00227786

Health Authority: United States: Federal Government

Clinical trial summary from the National Cancer Institute's PDQ® database